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POSSIBLE SYNERGISTIC ACTION BETWEEN
CARBAMAZEPINE AND LITHIUM CARBONATE IN THE
TREATMENT OF A MANIC PATIENT
JOHN MATT DORN, M.D .

Int roduction
Carbamazepine has been proven to be efficacious in some pati ent s with affective
disorders, notably those who have not responded well to lithium ca rbona te or
neuro leptics (1,2,3) . For those who have responded poorly to either regimen, however,
there have been no effective pharmacotherapies until recently, when case reports have
suggested a possible synergistic action between lithium carbonat e a nd carba mazepine
(4,5,6). The following case report supports this hypothesis.

Case Report
A 43-year-old man diagnosed by DSM-III criteria as having a bipola r disorder,
manic type , was admitted to a psychiatric hospital, Coatesville VA Medical Center, for
the fourth time in two years . Admission physical and laboratory results, as well as a n
EEG, were unremarkable. During previous admissions, thi s pati ent had remained
unimproved despite adequate trials of a combination of lithium carbonate at plasma
levels of 1.0-1 .5 mliq / Iiter and high doses of various classes of neuroleptics. Aga in, on
this admission, the patient was unc hanged despite high doses of neuroleptics, includ ing
chlorpromazine at up to 2000 mg.j'day, and lithium carbonate a t levels of 0.9-1.5
rnliq / Iiter. On day eighteen carbamazepine was begun. Wihin four days th e pa tient
displayed mar ked reduction of psychomotor agitation, aggressiveness, and irritab ility,
and on the twenty-second hospital day his ch lorpromazine was discontinued. H is
improveme nt contin ued with abatement of manic symptoms. On the fifty-seventh
hospital day, lithium carbonate was stopped to evalu ate the patient 's reponse to

carbamazepine alone. His carbamazepine level, which ranged from 4.6-6. 7 ugj ml
(therapeutic range for seizure disorde rs: 3-12 ug / rnl), was then 6.7 ug/ rnl. The pat ient
displayed a gra dual rec ru descence of manic symptoms, including violent threat s and
insomnia, as well as the new com plaint of bru xism. Following reinstitution of lithium
carbonate on day seventy -seven, the patient's manic symptoms a nd his complai nts of
bruxism resolved within three days . He was disc harged from the hospit al without
recurrence of his ma nic symptoms on the one-hundred-and-fifth hospital day. Four
months after discharge, he remains euthymic.
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Discussion
This patient responded poorl y to neuroleptics and lith ium carbonate, but
improved rapidly on a combination of carbam azepine a nd lithium carbonate. When an
attempt was made to discontinue the lithium carbonat e, the patient develop ed a
recurrence of his manic symptoms that resolved when it was reinstitu ted . Wh ile it
remains impossible to excl ude a sponta neous remission , th e temporal relationship
between treatment and symptom respon se appear s to support th e hypoth esis that this
patient , while unrespon sive to lithium carbonate a nd carbam azepine alone, responded
to a synergistic effect of the se drugs.
Elaboration of this proposed hypothesis awa its elucidati on of the methods of
action of the individual agents. Although a number of hypotheses exist (2, 7, 8) , their
incipient nature make speculation about the mechanism of ac tio n of these agents'
a ppa rent synergism premature.
While thi s and other case reports suggest the usefulness of a com bination of
lithi um carbonate and carbamazepine in otherwise tre atment-resist an t ma nic patients,
its role as a treatment modality in affective disorders, including its poten tial risks (6),
remain uncertainties th at merit further study.
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